{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:04:04Z","timestamp":1762376644719,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32\u2009kDa (DARPP-32) integrates dopaminergic signaling into that of several other neurotransmitters. Calcineurin (CaN), located downstream of dopaminergic pathways, inactivates DARPP-32 by dephosphorylation. Despite several studies have examined their expression levels of gene and protein in postmortem patients\u2019 brains, they rendered inconsistent results. In this study, protein expression levels of DARPP-32 and CaN were measured by enzyme-linked immunosorbent assay (ELISA) in the prefrontal cortex (PFC), and nucleus accumbens (NAc) of 49 postmortem samples from subjects with schizophrenia, bipolar disorder, and normal controls. We also examined the association between this expression and genetic variants of 8 dopaminergic system-associated molecules for 55 SNPs in the same postmortem samples. In the PFC of patients with schizophrenia, levels of DARPP-32 were significantly decreased, while those of CaN tended to increase. In the NAc, both of DARPP-32 and CaN showed no significant alternations in patients with schizophrenia or bipolar disorder. Further analysis of the correlation of DARPP-32 and CaN expressions, we found that positive correlations in controls and schizophrenia in PFC, and schizophrenia in NAc. In PFC, the expression ratio of DARPP-32\/CaN were significantly lower in schizophrenia than controls. We also found that several of the aforementioned SNPs may predict protein expression, one of which was confirmed in a second independent sample set. This differential expression of DARPP-32 and CaN may reflect potential molecular mechanisms underlying the pathogenesis of schizophrenia and bipolar disorder, or differences between these two major psychiatric diseases.<\/jats:p>","DOI":"10.1038\/s41598-019-51456-7","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T10:07:34Z","timestamp":1571220454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder"],"prefix":"10.1038","volume":"9","author":[{"given":"Yasuto","family":"Kunii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-0322","authenticated-orcid":false,"given":"Mizuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-3208","authenticated-orcid":false,"given":"Junya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Akatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirooki","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"51456_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnmol.2014.00027","volume":"7","author":"JN Lugo","year":"2014","unstructured":"Lugo, J. N. et al. Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins. Front Mol Neurosci 7, 27, https:\/\/doi.org\/10.3389\/fnmol.2014.00027 (2014).","journal-title":"Front Mol Neurosci"},{"key":"51456_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000327603","volume":"64","author":"X Zhang","year":"2011","unstructured":"Zhang, X., Liu, X., Wang, D., Liu, H. & Hao, W. Conditioned place preference associated with level of palmitoylation of PSD-95 in rat hippocampus and nucleus accumbens. Neuropsychobiology 64, 211\u2013218, https:\/\/doi.org\/10.1159\/000327603 (2011).","journal-title":"Neuropsychobiology"},{"key":"51456_CR3","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1046\/j.1471-4159.1999.0722015.x","volume":"72","author":"A Nishi","year":"1999","unstructured":"Nishi, A., Snyder, G. L., Nairn, A. C. & Greengard, P. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J Neurochem 72, 2015\u20132021 (1999).","journal-title":"J Neurochem"},{"key":"51456_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1101\/lm.027201.112","volume":"19","author":"K Baumgartel","year":"2012","unstructured":"Baumgartel, K. & Mansuy, I. M. Neural functions of calcineurin in synaptic plasticity and memory. Learn Mem 19, 375\u2013384, https:\/\/doi.org\/10.1101\/lm.027201.112 (2012).","journal-title":"Learn Mem"},{"key":"51456_CR5","doi-asserted-by":"publisher","first-page":"34450","DOI":"10.1074\/jbc.274.48.34450","volume":"274","author":"A Asai","year":"1999","unstructured":"Asai, A. et al. High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem 274, 34450\u201334458 (1999).","journal-title":"J Biol Chem"},{"key":"51456_CR6","doi-asserted-by":"publisher","first-page":"926395","DOI":"10.1155\/2013\/926395","volume":"2013","author":"G Bersani","year":"2013","unstructured":"Bersani, G. et al. Manic-like psychosis associated with elevated trough tacrolimus blood concentrations 17 years after kidney transplant. Case Rep Psychiatry 2013, 926395, https:\/\/doi.org\/10.1155\/2013\/926395 (2013).","journal-title":"Case Rep Psychiatry"},{"key":"51456_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1017\/S1461145705006279","volume":"9","author":"E Corruble","year":"2006","unstructured":"Corruble, E. et al. Psychosis associated with elevated trough tacrolimus blood concentrations after combined kidney-pancreas transplant. Int J Neuropsychopharmacol 9, 493\u2013494, https:\/\/doi.org\/10.1017\/S1461145705006279 (2006).","journal-title":"Int J Neuropsychopharmacol"},{"key":"51456_CR8","doi-asserted-by":"publisher","first-page":"327 e325","DOI":"10.1016\/j.genhosppsych.2012.07.010","volume":"35","author":"N Krishna","year":"2013","unstructured":"Krishna, N., Chiappelli, J., Fischer, B. A. & Knight, S. Tacrolimus-induced paranoid delusions and fugue-like state. Gen Hosp Psychiatry 35, 327 e325\u2013327 e326, https:\/\/doi.org\/10.1016\/j.genhosppsych.2012.07.010 (2013).","journal-title":"Gen Hosp Psychiatry"},{"key":"51456_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archpsyc.59.8.705","volume":"59","author":"KA Albert","year":"2002","unstructured":"Albert, K. A. et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry 59, 705\u2013712 (2002).","journal-title":"Arch Gen Psychiatry"},{"key":"51456_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/syn.20292","volume":"60","author":"KL Baracskay","year":"2006","unstructured":"Baracskay, K. L., Haroutunian, V. & Meador-Woodruff, J. H. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex. Synapse 60, 271\u2013279, https:\/\/doi.org\/10.1002\/syn.20292 (2006).","journal-title":"Synapse"},{"key":"51456_CR11","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.pnpbp.2007.04.013","volume":"31","author":"M Ishikawa","year":"2007","unstructured":"Ishikawa, M., Mizukami, K., Iwakiri, M. & Asada, T. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31, 1177\u20131181, https:\/\/doi.org\/10.1016\/j.pnpbp.2007.04.013 (2007).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"51456_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00795-010-0524-1","volume":"44","author":"Y Kunii","year":"2011","unstructured":"Kunii, Y. et al. Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study. Med Mol Morphol 44, 190\u2013199, https:\/\/doi.org\/10.1007\/s00795-010-0524-1 (2011).","journal-title":"Med Mol Morphol"},{"key":"51456_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/mp.2012.174","volume":"19","author":"Y Kunii","year":"2014","unstructured":"Kunii, Y. et al. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol Psychiatry 19, 192\u2013199, https:\/\/doi.org\/10.1038\/mp.2012.174 (2014).","journal-title":"Mol Psychiatry"},{"key":"51456_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2990.2010.01128.x","volume":"37","author":"L Zhan","year":"2011","unstructured":"Zhan, L. et al. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol 37, 206\u2013219, https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01128.x (2011).","journal-title":"Neuropathol Appl Neurobiol"},{"key":"51456_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.pnpbp.2011.03.016","volume":"35","author":"Y Kunii","year":"2011","unstructured":"Kunii, Y. et al. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35, 1139\u20131143, https:\/\/doi.org\/10.1016\/j.pnpbp.2011.03.016 (2011).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"51456_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pnpbp.2014.03.014","volume":"53","author":"Y Kunii","year":"2014","unstructured":"Kunii, Y. et al. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2\/ANKK1 polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 53, 123\u2013128, https:\/\/doi.org\/10.1016\/j.pnpbp.2014.03.014 (2014).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"51456_CR17","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.pnpbp.2011.07.010","volume":"35","author":"K Nishiura","year":"2011","unstructured":"Nishiura, K. et al. Profiles of DARPP-32 in the insular cortex with schizophrenia: a postmortem brain study. Prog Neuropsychopharmacol Biol Psychiatry 35, 1901\u20131907, https:\/\/doi.org\/10.1016\/j.pnpbp.2011.07.010 (2011).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"51456_CR18","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.biopsych.2004.12.029","volume":"57","author":"SL Eastwood","year":"2005","unstructured":"Eastwood, S. L., Burnet, P. W. & Harrison, P. J. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry 57, 702\u2013710, https:\/\/doi.org\/10.1016\/j.biopsych.2004.12.029 (2005).","journal-title":"Biol Psychiatry"},{"key":"51456_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.schres.2005.12.843","volume":"83","author":"N Kozlovsky","year":"2006","unstructured":"Kozlovsky, N., Scarr, E., Dean, B. & Agam, G. Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls. Schizophr Res 83, 173\u2013177, https:\/\/doi.org\/10.1016\/j.schres.2005.12.843 (2006).","journal-title":"Schizophr Res"},{"key":"51456_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1523\/JNEUROSCI.04-01-00111.1984","volume":"4","author":"CC Ouimet","year":"1984","unstructured":"Ouimet, C. C., Miller, P. E., Hemmings, H. C. Jr. & Walaas, S. I. & Greengard, P. DARPP-32, a dopamine- and adenosine 3\u2032:5\u2032-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4, 111\u2013124 (1984).","journal-title":"J Neurosci"},{"key":"51456_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cne.903230206","volume":"323","author":"CC Ouimet","year":"1992","unstructured":"Ouimet, C. C., LaMantia, A. S., Goldman-Rakic, P., Rakic, P. & Greengard, P. Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain. J Comp Neurol 323, 209\u2013218, https:\/\/doi.org\/10.1002\/cne.903230206 (1992).","journal-title":"J Comp Neurol"},{"key":"51456_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000225979","volume":"87","author":"CB Mikell","year":"2009","unstructured":"Mikell, C. B. et al. The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia. Stereotact Funct Neurosurg 87, 256\u2013265, https:\/\/doi.org\/10.1159\/000225979 (2009).","journal-title":"Stereotact Funct Neurosurg"},{"key":"51456_CR23","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1523\/JNEUROSCI.20-06-02369.2000","volume":"20","author":"SN Haber","year":"2000","unstructured":"Haber, S. N., Fudge, J. L. & McFarland, N. R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20, 2369\u20132382 (2000).","journal-title":"J Neurosci"},{"key":"51456_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biopsych.2010.10.032","volume":"69","author":"JE Kleinman","year":"2011","unstructured":"Kleinman, J. E. et al. Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 69, 140\u2013145, https:\/\/doi.org\/10.1016\/j.biopsych.2010.10.032 (2011).","journal-title":"Biol Psychiatry"},{"key":"51456_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jamapsychiatry.2014.157","volume":"71","author":"D Dickinson","year":"2014","unstructured":"Dickinson, D. et al. Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals. JAMA Psychiatry 71, 647\u2013656, https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.157 (2014).","journal-title":"JAMA Psychiatry"},{"key":"51456_CR26","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1523\/JNEUROSCI.1423-13.2014","volume":"34","author":"Y Morita","year":"2014","unstructured":"Morita, Y. et al. Characteristics of the cation cotransporter NKCC1 in human brain: alternate transcripts, expression in development, and potential relationships to brain function and schizophrenia. J Neurosci 34, 4929\u20134940, https:\/\/doi.org\/10.1523\/JNEUROSCI.1423-13.2014 (2014).","journal-title":"J Neurosci"},{"key":"51456_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.74","volume":"5","author":"SM O\u2019Donovan","year":"2015","unstructured":"O\u2019Donovan, S. M. et al. Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia. Transl Psychiatry 5, e579, https:\/\/doi.org\/10.1038\/tp.2015.74 (2015).","journal-title":"Transl Psychiatry"},{"key":"51456_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.45","volume":"5","author":"K Ohi","year":"2015","unstructured":"Ohi, K. et al. DEGS2 polymorphism associated with cognition in schizophrenia is associated with gene expression in brain. Transl Psychiatry 5, e550, https:\/\/doi.org\/10.1038\/tp.2015.45 (2015).","journal-title":"Transl Psychiatry"},{"key":"51456_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpsychires.2016.07.018","volume":"82","author":"M Hino","year":"2016","unstructured":"Hino, M. et al. Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia. J Psychiatr Res 82, 100\u2013108, https:\/\/doi.org\/10.1016\/j.jpsychires.2016.07.018 (2016).","journal-title":"J Psychiatr Res"},{"key":"51456_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.schres.2008.05.014","volume":"103","author":"LA Feldcamp","year":"2008","unstructured":"Feldcamp, L. A., Souza, R. P., Romano-Silva, M., Kennedy, J. L. & Wong, A. H. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia. Schizophr Res 103, 192\u2013200, https:\/\/doi.org\/10.1016\/j.schres.2008.05.014 (2008).","journal-title":"Schizophr Res"},{"key":"51456_CR31","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1176\/appi.ajp.162.10.1859","volume":"162","author":"SM Clinton","year":"2005","unstructured":"Clinton, S. M. et al. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. Am J Psychiatry 162, 1859\u20131871, https:\/\/doi.org\/10.1176\/appi.ajp.162.10.1859 (2005).","journal-title":"Am J Psychiatry"},{"key":"51456_CR32","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1073\/pnas.081071198","volume":"98","author":"Y Hakak","year":"2001","unstructured":"Hakak, Y. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98, 4746\u20134751, https:\/\/doi.org\/10.1073\/pnas.081071198 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"51456_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pnpbp.2012.01.005","volume":"37","author":"A Wada","year":"2012","unstructured":"Wada, A. et al. Increased ratio of calcineurin immunoreactive neurons in the caudate nucleus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 37, 8\u201314, https:\/\/doi.org\/10.1016\/j.pnpbp.2012.01.005 (2012).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"51456_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.psychres.2016.11.018","volume":"247","author":"A Wada","year":"2017","unstructured":"Wada, A. et al. Prominent increased calcineurin immunoreactivity in the superior temporal gyrus in schizophrenia: A postmortem study. Psychiatry Res 247, 79\u201383, https:\/\/doi.org\/10.1016\/j.psychres.2016.11.018 (2017).","journal-title":"Psychiatry Res"},{"key":"51456_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","volume":"23","author":"P Greengard","year":"1999","unstructured":"Greengard, P., Allen, P. B. & Nairn, A. C. Beyond the dopamine receptor: the DARPP-32\/protein phosphatase-1 cascade. Neuron 23, 435\u2013447 (1999).","journal-title":"Neuron"},{"key":"51456_CR36","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.1073\/pnas.1432927100","volume":"100","author":"DJ Gerber","year":"2003","unstructured":"Gerber, D. J. et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA 100, 8993\u20138998, https:\/\/doi.org\/10.1073\/pnas.1432927100 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"51456_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.mp.4002019","volume":"12","author":"Y Horiuchi","year":"2007","unstructured":"Horiuchi, Y. et al. Support for association of the PPP3CC gene with schizophrenia. Mol Psychiatry 12, 891\u2013893, https:\/\/doi.org\/10.1038\/sj.mp.4002019 (2007).","journal-title":"Mol Psychiatry"},{"key":"51456_CR38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00702-004-0261-5","volume":"112","author":"Y Kinoshita","year":"2005","unstructured":"Kinoshita, Y. et al. No association with the calcineurin A gamma subunit gene (PPP3CC) haplotype to Japanese schizophrenia. J Neural Transm (Vienna) 112, 1255\u20131262, https:\/\/doi.org\/10.1007\/s00702-004-0261-5 (2005).","journal-title":"J Neural Transm (Vienna)"},{"key":"51456_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1176\/appi.ajp.2007.07101573","volume":"165","author":"AR Sanders","year":"2008","unstructured":"Sanders, A. R. et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 165, 497\u2013506, https:\/\/doi.org\/10.1176\/appi.ajp.2007.07101573 (2008).","journal-title":"Am J Psychiatry"},{"key":"51456_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.schres.2006.10.012","volume":"90","author":"Z Xi","year":"2007","unstructured":"Xi, Z. et al. No association between PPP3CC and schizophrenia in the Chinese population. Schizophr Res 90, 357\u2013359, https:\/\/doi.org\/10.1016\/j.schres.2006.10.012 (2007).","journal-title":"Schizophr Res"},{"key":"51456_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-4-2","volume":"4","author":"F Mathieu","year":"2008","unstructured":"Mathieu, F. et al. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder. Behav Brain Funct 4, 2, https:\/\/doi.org\/10.1186\/1744-9081-4-2 (2008).","journal-title":"Behav Brain Funct"},{"key":"51456_CR42","doi-asserted-by":"publisher","first-page":"8987","DOI":"10.1073\/pnas.1432926100","volume":"100","author":"T Miyakawa","year":"2003","unstructured":"Miyakawa, T. et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100, 8987\u20138992, https:\/\/doi.org\/10.1073\/pnas.1432926100 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"51456_CR43","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1006\/bbrc.1993.2404","volume":"196","author":"M Itokawa","year":"1993","unstructured":"Itokawa, M., Arinami, T., Futamura, N., Hamaguchi, H. & Toru, M. A structural polymorphism of human dopamine D2 receptor, D2(Ser311\u2013>Cys). Biochem Biophys Res Commun 196, 1369\u20131375, https:\/\/doi.org\/10.1006\/bbrc.1993.2404 (1993).","journal-title":"Biochem Biophys Res Commun"},{"key":"51456_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0140-6736(94)91581-4","volume":"343","author":"T Arinami","year":"1994","unstructured":"Arinami, T. et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343, 703\u2013704 (1994).","journal-title":"Lancet"},{"key":"51456_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ajmg.b.30273","volume":"141B","author":"SJ Glatt","year":"2006","unstructured":"Glatt, S. J. & Jonsson, E. G. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am J Med Genet B Neuropsychiatr Genet 141B, 149\u2013154, https:\/\/doi.org\/10.1002\/ajmg.b.30273 (2006).","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"51456_CR46","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.2147\/NDT.S118614","volume":"12","author":"H He","year":"2016","unstructured":"He, H. et al. Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis. Neuropsychiatr Dis Treat 12, 3129\u20133144, https:\/\/doi.org\/10.2147\/NDT.S118614 (2016).","journal-title":"Neuropsychiatr Dis Treat"},{"key":"51456_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12993-016-0114-z","volume":"12","author":"TB Gonzalez-Castro","year":"2016","unstructured":"Gonzalez-Castro, T. B. et al. The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis. Behav Brain Funct 12, 29, https:\/\/doi.org\/10.1186\/s12993-016-0114-z (2016).","journal-title":"Behav Brain Funct"},{"key":"51456_CR48","first-page":"560","volume":"49","author":"M Itokawa","year":"1996","unstructured":"Itokawa, M. et al. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells. Mol Pharmacol 49, 560\u2013566 (1996).","journal-title":"Mol Pharmacol"},{"key":"51456_CR49","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1096\/fasebj.4.11.2165947","volume":"4","author":"WP Hausdorff","year":"1990","unstructured":"Hausdorff, W. P., Caron, M. G. & Lefkowitz, R. J. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 4, 2881\u20132889 (1990).","journal-title":"FASEB J"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51456-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:44:02Z","timestamp":1671288242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51456"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51456-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14877"}}